ClinicalTrials.gg
Sign In

Myalgia clinical trials

The registry lists 256 studies for Myalgia across more than 10 countries. 46 are recruiting or about to start. 156 of them are mainly about Myalgia (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06.

Get an email when these change. Save the Myalgia studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
167
Status unknown
27
Recruiting
27
Not yet recruiting
12
Enrolling by invitation
7
Terminated
6

Phase

Phase 2
29
Phase 3
23
Phase 4
16
Phase 1
11
Early Phase 1
2

Where

United States
86
Turkey
21
Spain
14
United Kingdom
12
Poland
11
Pakistan
10

Who runs them

Riphah International University (7) · Wroclaw Medical University (5) · Rutgers, The State University of New Jersey (3) · Jazz Pharmaceuticals (3) · Aalborg University (3) · Karolinska Institutet (3) · Indiana University (3) · Universidade Federal do Rio Grande do Norte (3)

What is being tested here

Drugs under test in Myalgia studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Botulinum toxin type A102
Hydrogen Rich Water101
Loxoprofen101
Lidocaine101
Sodium Bicarbonate101
Tyrosol101
Creatine monohydrate101
Creatine101
Methylprednisolone Acetate101
Methylprednisolone101

Drug classes tested here NSAIDs 1 open · Statins 3

Coming up

1phase 3 study under way
19studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 27 Myalgia studies recruiting now, 6 (22%) set no upper age limit and 20 (74%) stop at 75 or younger. 4 (15%) take children under 18. 1 (4%) are for women only and 3 (11%) for men only; 17 (63%) take healthy volunteers.

Recruiting studies that take each age, of 27
AgeWomenMen
101 (4%)1 (4%)
1823 (85%)24 (89%)
3024 (89%)25 (93%)
4020 (74%)22 (81%)
5016 (59%)17 (63%)
6513 (48%)13 (48%)
758 (30%)8 (30%)
857 (26%)7 (26%)

Across all 256 studies, recruiting or not: 67% stop at 75 or younger and 61% at 65; 8% take children; 6% are for women only and 14% for men only; 61% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Myalgia studies take

Of 111 interventional studies with no phase under Myalgia, half reached primary completion within 8 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase8 mo3–16 · 111 studies—8 mo3–16 · 101 studies
Observational14 mo4–… · 19 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Started recruiting2

Newly registered3

Studies

Recruiting first, then most recently updated. Showing 50 of 256. Browse all 256 → or search them.